10.08 / 22:05
Life
FDA
Monkeypox
Strategy
The FDA just made a big change to monkeypox vaccine strategy
Following a lackluster initial response to monkeypox, the Food and Drug Administration (FDA) has announced a new strategy aimed at maximizing the still-limited supply of the Jynneos vaccine.On Tuesday, the FDA authorized emergency use of the vaccine against the disease, allowing for a single dose to be split into five smaller doses.“In recent weeks the monkeypox virus has continued to spread at a rate that has made it clear our current vaccine supply will not meet the current demand,” said FDA Commissioner Robert M. Califf, M.D.
